Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Among patients with newly diagnosed advanced ovarian cancer who had a response to platinum-based chemotherapy, those who received niraparib had significantly longer progression-...
Publications
View AllLenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
Lenvatinib plus pembrolizumab was associated with significantly longer progression-free survival and overall survival than sunitinib. (Funded by Eisai and Merck Sharp and Dohme;...
Affiliated Researchers
Institution Info
- Type
- healthcare
- Country
- ES
- Publications
- 2
- Citations
- 3,659
External Links
Identifiers
- ROR
- https://ror.org/02vtd2q19